Breath Analyzers: A Global Strategic Business Report
San Jose, California (PRWEB) March 13, 2012
Follow us on LinkedIn – Breath analyzers are analytical instruments designed to analyze the human breath to diagnose both diseases and for estimating blood alcohol levels. Widely used for alcohol testing, the device measures the level of alcohol in exhaled air based on the alcohol in the blood circulating through the lungs. Infrared Spectrophotometer, Fuel Cell, and Semiconductor Sensor technologies are the three different testing platforms for alcohol breath analyzers. Currently, diagnostic applications of breath analyzers include testing for bacterial overgrowth, identifying gastrointestinal disorders, measuring liver function, studying gastric emptying and intestinal transit time, and diagnosing urinary tract infections, among others. Carbon monoxide breath analyzers are based on infrared and electrochemical sensors to measure the concentration of carbon dioxide and carbon monoxide in a patient’s breath to identify respiratory disorders.
Rising public outcry against the growing number of injuries and deaths caused by drunk driving is a fundamental demand driver for alcohol breath analyzers. Inebriation due to alcohol consumption is a serious threat to lives and properties of drivers and non-drivers. Inexperienced alcohol-impaired young drivers are 2.5 times more likely to die in road accidents than older, experienced drivers. Several measures are being enforced globally for curbing drunk driving, such as setting up of legal limits for Blood Alcohol Concentration (BAC), testing drivers’ BAC levels with the help of Breath Analyzers and by making drunk driving a criminal offense resulting in severe penalties. The offense of operating a vehicle with a blood alcohol concentration beyond the legally permissible limit is variously referred to as ‘driving while intoxicated’ (DWI), and ‘driving under the influence’ (DUI). Breath Analyzers that show objective evidence of BAC are extremely effective law enforcement tools and act as excellent drunk driving deterrents. Alcohol enforcement has and will continue to remain a priority for governments across the globe and countries across the world are formulating tougher alcohol abuse prevention laws thereby intensifying the enforcement of current laws. Against this backdrop law enforcement breath analyzers are poised to score gains in the upcoming years.
In addition, growing emphasis on preventing alcohol abuse at the workplace, together with the regulatory impetus offered by acts such as the Drug-Free Workplace Act of 1988 in the US, will continue to help drive demand for alcohol breath analyzers. Employee screening for substance abuse in the upcoming years is poised to evolve into a voluntary good business practice unlike the current scenario where such corporate programs are drafted only under obligatory compliance with the act.
Promising opportunities for growth also exists in the area of medical diagnostics, especially so given the ability of breath analyzers to provide preventative screening and diagnostics for health-clinic and home use. Similar to a conventional breath analyzer that determines the alcohol content in a driver's breath, the medical breath analysis instruments determine biomarkers associated with specific disease conditions when present in more-than-normal concentrations. By sampling patients’ breath, the device offers promise to yield inexpensive, faster indications of disease conditions such as cancers, diabetes, asthma, kidney disease, ischemic heart disease and other diseases, early enough to enhance the chances of successful treatment. Also, quantification of breath alcohol concentration (BAC) is a vital input in medical diagnosis and emergency medical care. In certain emergency cases, such as psychological illness, head injuries, heart attack, stroke, diabetes, the patients’ medical condition can be confused with alcohol intoxication causing misdiagnosis, or delay of diagnostic procedure.
As stated by the new market research report on Breath Analyzers, the United States represents the largest market worldwide, followed by Europe. Asia-Pacific remains the fastest growing regional market with a projected CAGR of 8.8% over the analysis period. Healthcare as an end-use industry is expected to offer the strongest opportunities for future growth in the marketplace.
Major players in the marketplace include Akers Biosciences Inc., AlcoPro Inc., Advanced Safety Devices LLC, Alcohol Countermeasure Systems Corp., CMI Inc., Drägerwerk AG & Co., KgaA, Ekips Technologies Inc., Guth Laboratories Inc., Intoximeters Inc., Lion Laboratories Ltd., Lifeloc Technologies Inc., PAS Systems International Inc., among others.
The research report titled “Breath Analyzers: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections (in US$) for major geographic markets including the United States, Canada, Europe, Asia-Pacific, and Rest of World. End Use segments analyzed include Regulatory Authorities, Employee Screening, and Healthcare.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/